Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...
Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease treatments.
In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.
Morning Overview on MSN
Parkinson’s breakthrough rewrites what we know about dopamine
For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...
A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A drug used for ...
Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...
A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results